Your browser is no longer supported. Please, upgrade your browser.
PRGO Perrigo Company plc monthly Stock Chart
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-20.55 Insider Own0.10% Shs Outstand143.39M Perf Week0.36%
Market Cap11.12B Forward P/E15.25 EPS next Y5.09 Insider Trans0.00% Shs Float141.65M Perf Month1.80%
Income-2947.30M PEG- EPS next Q1.11 Inst Own86.40% Short Float10.13% Perf Quarter8.72%
Sales5.02B P/S2.21 EPS this Y-9.70% Inst Trans6.69% Short Ratio8.22 Perf Half Y-8.37%
Book/sh42.44 P/B1.83 EPS next Y11.07% ROA-21.20% Target Price79.00 Perf Year-15.52%
Cash/sh- P/C- EPS next 5Y7.80% ROE-46.10% 52W Range63.68 - 99.14 Perf YTD-6.79%
Dividend0.64 P/FCF19.26 EPS past 5Y-54.10% ROI-9.90% 52W High-21.75% Beta0.67
Dividend %0.82% Quick Ratio1.20 Sales past 5Y10.70% Gross Margin38.60% 52W Low21.83% ATR2.26
Employees12800 Current Ratio1.70 Sales Q/Q-7.70% Oper. Margin-36.10% RSI (14)58.22 Volatility1.94% 2.61%
OptionableYes Debt/Eq0.60 EPS Q/Q87.00% Profit Margin-58.70% Rel Volume0.63 Prev Close77.27
ShortableYes LT Debt/Eq0.54 EarningsAug 10 BMO Payout- Avg Volume1.74M Price77.58
Recom2.80 SMA204.89% SMA505.08% SMA2001.85% Volume1,104,630 Change0.40%
Aug-11-17Upgrade Goldman Sell → Neutral
Aug-11-17Reiterated RBC Capital Mkts Underperform $60 → $64
Jun-16-17Initiated Cantor Fitzgerald Overweight $85
Jun-05-17Downgrade RBC Capital Mkts Sector Perform → Underperform $66 → $60
Mar-03-17Reiterated B. Riley & Co. Neutral $83 → $67
Feb-28-17Reiterated Canaccord Genuity Buy $100 → $97
Feb-22-17Initiated Canaccord Genuity Buy $100
Jan-23-17Reiterated Jefferies Hold $84 → $70
Jan-17-17Reiterated RBC Capital Mkts Sector Perform $92 → $85
Nov-11-16Upgrade BofA/Merrill Underperform → Neutral
Nov-11-16Reiterated B. Riley & Co. Neutral $87 → $97
Aug-11-16Reiterated Barclays Overweight $120 → $110
Jul-22-16Upgrade Deutsche Bank Hold → Buy $115
Jun-20-16Downgrade Argus Buy → Hold
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Feb-19-16Initiated Wells Fargo Outperform
Aug-21-17 09:00AM  Perrigo Announces Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium® 24HR Capsules PR Newswire
07:10AM  Earnings Review and Free Research Report: Perrigo Reported Better than Expected Revenue and Earnings Results ACCESSWIRE
Aug-16-17 08:51AM  Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog® II Cream PR Newswire
Aug-14-17 04:12PM  Perrigo: Still A Hard Pill To Swallow
12:06PM  Edited Transcript of PRGO earnings conference call or presentation 10-Aug-17 12:00pm GMT Thomson Reuters StreetEvents
11:49AM  The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant Zacks
Aug-12-17 08:06AM  See what the IHS Markit Score report has to say about Perrigo Company PLC. Markit
Aug-11-17 10:27AM  Perrigo is the rare generic drugmaker that isnt suffering right now MarketWatch
09:58AM  Company News For August 11, 2017 Zacks
08:07AM  Perrigo upgraded to neutral by Goldman MarketWatch
07:05AM  Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure Zacks
Aug-10-17 08:02PM  Perrigo reports 2Q loss Associated Press +15.78%
06:15PM  Perrigo Unveils Divestitures, Says It's Open to Making Bolt-On Acquisitions
04:34PM  The Hot Stock: Perrigo Soars 16%
04:29PM  Why Pan American Silver, Chefs' Warehouse, and Perrigo Jumped Today Motley Fool
04:14PM  Perrigo (PRGO) Q2 Earnings & Sales Top, 2017 View Raised Zacks
12:51PM  Kohl's, Dillard's, Live Nation Entertainment Moving Despite International Tensions
12:31PM  [$$] SK Capital to Buy Perrigo's Active Pharmaceutical Ingredients Business The Wall Street Journal
12:18PM  Here's Why Perrigo Company Rose as Much as 20.5% Today Motley Fool
11:22AM  Why Perrigo is Soaring
10:01AM  These Biotech Stocks are BOOMING
08:58AM  Perrigo Co. shares surge 12% after Q2 profit, revenue beats MarketWatch
08:23AM  Morning Movers: Macy's, Perrigo Gain on Earnings; Dillard's, Chicago Bridge Tumble
08:05AM  IHS Markit Score Update: Drop in demand for ETFs holding Perrigo Company PLC is a negative sign for its shares Markit
07:43AM  Early movers: KSS, APRN, GOOS, PRGO, EAT, DAL, FOXA, JACK, ELF & more CNBC
07:37AM  US STOCKS-Futures lower as N.Korea tensions extend to third day Reuters
02:02AM  Perrigo Company plc Reports Second Quarter 2017 Financial Results PR Newswire
Aug-08-17 10:51AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
09:38AM  Endo's U.S. generics business beats estimates Reuters
Aug-07-17 11:27PM  Perrigo Company (PRGO) Q2 Earnings: What's in the Cards? Zacks
Aug-04-17 09:20AM  Perrigo Announces Tentative FDA Approval For Generic Version Of Mirvaso® Gel PR Newswire
Aug-03-17 09:53AM  Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : August 3, 2017 Capital Cube -5.30%
Aug-01-17 07:20PM  Perrigo Co. Plc Value Analysis (NYSE:PRGO) : August 1, 2017 Capital Cube
Jul-31-17 09:20AM  Perrigo Announces The Launch Of The AB Rated Generic Version Of Transderm Scop® 1.5 mg PR Newswire
Jul-27-17 04:47PM  Perrigo To Release Second Quarter 2017 Financial Results On August 10, 2017 PR Newswire
Jul-24-17 06:17PM  ETFs with exposure to Perrigo Co. Plc : July 24, 2017 Capital Cube
12:30PM  Should You Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons InvestorPlace
Jul-19-17 09:13AM  Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : July 19, 2017 Capital Cube
08:57AM  Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of DermOtic® Oil, 0.01% Ear Drops PR Newswire
Jul-18-17 06:12PM  Perrigo Company Gets FDA Approval for Generic Topical Gel Zacks
Jul-17-17 09:08AM  Perrigo Confirms Patent Challenge For Generic Version Of Soolantra® Cream, 1% PR Newswire
09:07AM  Perrigo Announces FDA Final Approval For Its First-To-File Ab Rated Generic Version Of Androgel® Topical Gel, 1.62% Packets PR Newswire
09:06AM  Perrigo Announces Settlement Of Generic Version Of Dymista® Nasal Spray Patent Litigation PR Newswire
Jul-14-17 04:21PM  ETFs with exposure to Perrigo Co. Plc : July 14, 2017 Capital Cube
Jul-10-17 04:11PM  The Royalty-Amassing Strategy Of Royalty Pharma Benzinga
Jul-08-17 08:48AM  Activists Forced CEOs to Leave These Huge Companies This Year
Jul-07-17 09:44AM  Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : July 7, 2017 Capital Cube
Jul-06-17 09:12AM  [$$] The Angst of Endangered CEOs: 'How Much Time Do I Have?' The Wall Street Journal
12:06AM  [$$] The Angst of Endangered CEOs: How Much Time Do I Have? The Wall Street Journal
Jul-05-17 09:00AM  Perrigo Launches The Generic Version Of Axiron® Topical Solution PR Newswire
Jun-30-17 04:01AM  Why Is Perrigo (PRGO) Up 5% Since the Last Earnings Report? Zacks
Jun-29-17 01:29PM  Perrigo Finance Unlimited Company -- Moody's affirms Perrigo's Baa3 rating; revises outlook to stable Moody's
Jun-28-17 08:18AM  Here are the winners and losers in the health-care sector CNBC Videos
Jun-22-17 12:22PM  Health-Care Stocks Get a Boost From Senate Bill Rollout The Wall Street Journal
Jun-21-17 09:50AM  Perrigo Company Retains Spencer Stuart for CEO Search PR Newswire
08:32AM  Perrigo Announces the Launch of Generic Equivalents to Derma-Smoothe/FS® Scalp Oil and Body Oil PR Newswire
Jun-20-17 09:07AM  Dupixent May Be a Major Growth Driver for Regeneron in 2017 Market Realist
08:15AM  Earnings Highlights and Review: Perrigo Reported Better-than-Expected Quarterly Results Accesswire
Jun-19-17 09:13AM  Perrigo Announces the Launch of Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution PR Newswire
Jun-16-17 10:54AM  Valeant: Stop Looking in the Rearview Mirror!
Jun-15-17 03:02PM  ETFs with exposure to Perrigo Co. Plc : June 15, 2017 Capital Cube
Jun-14-17 01:38PM  Perrigo Company plc Announces Pricing for its Cash Tender Offer PR Newswire
09:25AM  Perrigo Co. Plc :PRGO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
09:12AM  Perrigo Company To Present At The 17th Annual Oppenheimer Consumer Conference PR Newswire
07:30AM  Perrigo Company plc Announces Early Tender Results for Cash Tender Offer PR Newswire
Jun-13-17 12:07PM  Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space
Jun-09-17 08:37AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : June 9, 2017 Capital Cube
Jun-08-17 01:00AM  Small is lucrative for Wachtell, corporate America's legal defense force Reuters
Jun-06-17 12:16PM  Perrigo: As the Revolving Door Spins
07:29AM  US STOCKS-Futures slip as investors turn risk averse Reuters
06:42AM  DISH to pay $280M in telemarking lawsuit CNBC Videos
12:28AM  [$$] Perrigo CEO to Leave After 14 Months The Wall Street Journal
12:11AM  PRESS DIGEST - Wall Street Journal - June 6 Reuters
Jun-05-17 07:09PM  Drugmaker Perrigo says CEO Hendrickson plans to retire Reuters
06:08PM  Drugmaker Perrigo says CEO Hendrickson plans to retire Reuters
06:00PM  [$$] Perrigo CEO to Leave After 14 Months The Wall Street Journal
05:22PM  After-hours buzz: ACOR, THO & more CNBC
05:13PM  Drugmaker Perrigo's CEO to retire Reuters
05:09PM  Perrigo says CEO Hendrickson to retire, search committee created MarketWatch
04:55PM  Perrigo Announces Forthcoming Retirement Of CEO John Hendrickson PR Newswire
11:31AM  Stocks Down As Apple Dips; IBD 50 Plays Generally Up Investor's Business Daily
Jun-02-17 08:03AM  Perrigo Company To Present At The Jefferies 2017 Healthcare Conference PR Newswire
Jun-01-17 11:01AM  Company News for June 01, 2017 Zacks
08:35AM  Edited Transcript of PRGO earnings conference call or presentation 31-May-17 12:30pm GMT Thomson Reuters StreetEvents
12:09AM  [$$] Miracle Cure a Long Shot for Perrigo The Wall Street Journal
May-31-17 05:16PM  What Happened in the Stock Market Today Motley Fool +7.26%
04:28PM  The Hot Stock: Perrigo Jumps 7.3%
02:11PM  Perrigo Stock Jumps on 1Q Beat
01:10PM  Perrigo: There Goes the Overhang!
12:16PM  [$$] Miracle Cure a Long Shot for Perrigo The Wall Street Journal
11:17AM  Adjustments to Model for Perrigo, Fair Value Unchanged Morningstar
11:16AM  Story Stocks from
10:25AM  Perrigo's (PRGO) Q1 Earnings Beat Estimates, Guidance Intact Zacks
07:35AM  Perrigo Company plc Announces $1,400,000,000 Cash Tender Offer for Certain Notes PR Newswire
May-30-17 05:26PM  Perrigo tops Street 1Q forecasts Associated Press
05:18PM  Perrigo To Conduct Conference Call On May 31, 2017 At 8:30 AM ET PR Newswire
05:14PM  Perrigo Company plc Files First Quarter 2017 Form 10-Q And Reports First Quarter 2017 Financial Results PR Newswire
06:49AM  Market Recon: Watch Core Inflation for a Hint of What the Fed Will Do
May-29-17 08:23AM  Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : May 29, 2017 Capital Cube
May-26-17 04:45AM  Edited Transcript of PRGO earnings conference call or presentation 23-May-17 12:30pm GMT Thomson Reuters StreetEvents
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. It offers OTC products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. The company also provides generic and specialty pharmaceutical prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services; and generic pharmaceutical products. The company offers its products through retail drug, supermarket, mass merchandise chains, wholesalers, pharmacies, drug and grocery stores, para pharmacies, and hospitals, as well as through a network of pharmacy sales force and pharmacists in North America, Europe, Australia, Israel, China, and Latin America. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Alford Bradley ADirectorJul 20Option Exercise75.511,01776,7941,017Jul 24 04:56 PM
Parker Geoffrey M.DirectorJul 20Option Exercise75.511,948147,0931,437Jul 24 04:54 PM
Samuels Theodore R. IIDirectorJul 20Option Exercise75.511,359102,6181,359Jul 24 04:49 PM
KINDLER JEFFREY BDirectorJul 20Option Exercise75.511,01776,7941,017Jul 24 04:47 PM
Smith Jeffrey CDirectorJul 20Option Exercise75.511,01776,7941,017Jul 24 04:25 PM
BRLAS LAURIEDirectorJun 21Option Exercise73.3377857,05112,931Jun 22 04:44 PM
Needham JeffreyEVP, President CHC AmericasMay 31Option Exercise72.8551537,51811,419Jun 02 12:40 PM
O'Connor DonalDirectorMay 31Option Exercise72.853,263237,7104,875Jun 02 12:37 PM
BRLAS LAURIEDirectorMay 31Option Exercise72.853,263237,71013,720Jun 02 12:35 PM
COHEN GARY MDirectorMay 31Option Exercise72.853,263237,71016,614Jun 02 12:30 PM
Wesolowski JohnEVP, President RxDec 15Option Exercise82.6132526,848325Dec 19 04:07 PM
Brown Judy LEVP, Business Ops & CFONov 25Sale89.442,097187,55610,007Nov 28 04:29 PM
Parker Geoffrey M.DirectorNov 21Buy88.752,500221,8752,500Nov 21 03:14 PM
KINGMA TODD WExecutive VP, General CounselNov 21Sale88.6875066,51214,560Nov 23 02:30 PM
Brown Judy LEVP, Business Ops & CFOOct 24Sale90.422,092189,15912,104Oct 26 02:44 PM
Farrington ThomasEVP and CIOSep 26Sale96.761,110107,4042,970Sep 28 01:47 PM
Brown Judy LEVP, Business Ops & CFOSep 26Sale96.762,096202,80914,196Sep 28 01:47 PM
KUNKLE GARY K JRDirectorSep 09Option Exercise16.775,81497,50131,501Sep 13 03:01 PM
KUNKLE GARY K JRDirectorSep 09Sale89.955,814522,97425,687Sep 13 03:01 PM
MORRIS HERMAN JRDirectorSep 08Option Exercise16.775,81497,50110,425Sep 09 04:33 PM
MORRIS HERMAN JRDirectorSep 08Sale90.961,07397,5959,352Sep 09 04:33 PM
Brown Judy LEVP, Business Ops & CFOAug 26Sale88.282,095184,94716,292Aug 30 04:38 PM
Weninger PaulEVP, Quality OperationsAug 22Option Exercise91.5218817,2062,296Aug 24 03:54 PM
Brown Judy LEVP, Business Ops & CFOAug 22Option Exercise91.522,877263,30319,717Aug 24 03:53 PM
Farrington ThomasEVP and CIOAug 22Option Exercise91.5269363,4234,299Aug 24 03:53 PM
Quinn GrainneEVP, Chief Medical OfficerAug 22Option Exercise91.522,168198,4153,208Aug 24 03:53 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 22Option Exercise91.521,336122,27111,327Aug 24 03:52 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainAug 22Option Exercise91.5230127,5481,586Aug 24 03:52 PM
HENDRICKSON JOHN TCEOAug 22Option Exercise91.521,536140,5755,401Aug 24 03:52 PM
Kochan SharonEVP, GM InternationalAug 22Option Exercise91.521,336122,27110,088Aug 24 03:51 PM
KINGMA TODD WExecutive VP, General CounselAug 22Option Exercise91.521,536140,57515,796Aug 23 04:58 PM